Upgrade to SI Premium - Free Trial

Allergan (AGN) Receives FDA Approval of Juvederm VOLUMA XC For Mid-Face Injection Via Cannula

September 3, 2019 7:32 AM
Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles